Logo image of ICCM

ICECURE MEDICAL LTD (ICCM) Stock Fundamental Analysis

NASDAQ:ICCM - Nasdaq - IL0011224156 - Common Stock - Currency: USD

1.41  -0.09 (-6%)

Fundamental Rating

3

Overall ICCM gets a fundamental rating of 3 out of 10. We evaluated ICCM against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of ICCM is average, but there are quite some concerns on its profitability. ICCM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ICCM has reported negative net income.
In the past year ICCM has reported a negative cash flow from operations.
ICCM had negative earnings in each of the past 5 years.
ICCM had a negative operating cash flow in each of the past 5 years.
ICCM Yearly Net Income VS EBIT VS OCF VS FCFICCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -90.55%, ICCM is doing worse than 81.91% of the companies in the same industry.
Looking at the Return On Equity, with a value of -137.51%, ICCM is doing worse than 71.28% of the companies in the same industry.
Industry RankSector Rank
ROA -90.55%
ROE -137.51%
ROIC N/A
ROA(3y)-58.73%
ROA(5y)-55.17%
ROE(3y)-74.66%
ROE(5y)-93.29%
ROIC(3y)N/A
ROIC(5y)N/A
ICCM Yearly ROA, ROE, ROICICCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600 800 1K

1.3 Margins

ICCM has a worse Gross Margin (43.67%) than 63.83% of its industry peers.
ICCM's Gross Margin has been stable in the last couple of years.
ICCM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.89%
GM growth 5Y-0.83%
ICCM Yearly Profit, Operating, Gross MarginsICCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

6

2. Health

2.1 Basic Checks

ICCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICCM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICCM has more shares outstanding
ICCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICCM Yearly Shares OutstandingICCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ICCM Yearly Total Debt VS Total AssetsICCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.33, we must say that ICCM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ICCM (-2.33) is worse than 62.23% of its industry peers.
ICCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.33
ROIC/WACCN/A
WACC9.11%
ICCM Yearly LT Debt VS Equity VS FCFICCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ICCM has a Current Ratio of 2.67. This indicates that ICCM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.67, ICCM is in line with its industry, outperforming 50.53% of the companies in the same industry.
ICCM has a Quick Ratio of 2.27. This indicates that ICCM is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ICCM (2.27) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.27
ICCM Yearly Current Assets VS Current LiabilitesICCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.17% over the past year.
The Revenue has grown by 25.98% in the past year. This is a very strong growth!
Measured over the past years, ICCM shows a very strong growth in Revenue. The Revenue has been growing by 23.59% on average per year.
EPS 1Y (TTM)20.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.05%
Revenue 1Y (TTM)25.98%
Revenue growth 3Y-5.86%
Revenue growth 5Y23.59%
Sales Q2Q%106.88%

3.2 Future

Based on estimates for the next years, ICCM will show a very strong growth in Earnings Per Share. The EPS will grow by 25.22% on average per year.
The Revenue is expected to grow by 94.35% on average over the next years. This is a very strong growth
EPS Next Y3.56%
EPS Next 2Y7.24%
EPS Next 3Y9.51%
EPS Next 5Y25.22%
Revenue Next Year11.03%
Revenue Next 2Y34.4%
Revenue Next 3Y45.17%
Revenue Next 5Y94.35%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICCM Yearly Revenue VS EstimatesICCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
ICCM Yearly EPS VS EstimatesICCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.2 -0.2 0.4 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICCM. In the last year negative earnings were reported.
Also next year ICCM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICCM Price Earnings VS Forward Price EarningsICCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICCM Per share dataICCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.24%
EPS Next 3Y9.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ICECURE MEDICAL LTD

NASDAQ:ICCM (2/21/2025, 8:27:27 PM)

1.41

-0.09 (-6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner Change-94.51%
Ins Owners48.54%
Ins Owner ChangeN/A
Market Cap79.76M
Analysts82.22
Price Target3.2 (126.95%)
Short Float %2.76%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.7%
Min EPS beat(2)-4.58%
Max EPS beat(2)15.97%
EPS beat(4)3
Avg EPS beat(4)5.58%
Min EPS beat(4)-4.58%
Max EPS beat(4)15.97%
EPS beat(8)6
Avg EPS beat(8)6.08%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-8.4%
Max Revenue beat(2)7.1%
Revenue beat(4)2
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-16.8%
Max Revenue beat(4)7.1%
Revenue beat(8)2
Avg Revenue beat(8)-14.9%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.73
P/FCF N/A
P/OCF N/A
P/B 7.93
P/tB 7.93
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.06
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -90.55%
ROE -137.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.67%
FCFM N/A
ROA(3y)-58.73%
ROA(5y)-55.17%
ROE(3y)-74.66%
ROE(5y)-93.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.89%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.14%
Cap/Sales 4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.27
Altman-Z -2.33
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)269.13%
Cap/Sales(3y)18.82%
Cap/Sales(5y)13.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.05%
EPS Next Y3.56%
EPS Next 2Y7.24%
EPS Next 3Y9.51%
EPS Next 5Y25.22%
Revenue 1Y (TTM)25.98%
Revenue growth 3Y-5.86%
Revenue growth 5Y23.59%
Sales Q2Q%106.88%
Revenue Next Year11.03%
Revenue Next 2Y34.4%
Revenue Next 3Y45.17%
Revenue Next 5Y94.35%
EBIT growth 1Y9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.38%
OCF growth 3YN/A
OCF growth 5YN/A